Understanding Equine Viral Arteritis (EAV) Pathology

Equine Viral Arteritis is a viral respiratory and reproductive disease caused by a member of the Arteriviridae family. Unlike Potomac Horse Fever, which is bacterial in origin, EVA is strictly viral. It primarily targets endothelial cells, leading to inflammation that compromises the integrity of blood vessels.

Mechanisms of Transmission and Shedding

The virus is transmitted via direct contact with infected horses or inhalation of aerosolized particles. Critically, stallions can become long-term carriers. The virus persists in the reproductive tract, specifically the accessory sex glands, allowing the stallion to shed the virus in semen long after the acute infection has passed. This is a primary differentiator compared to other common respiratory pathogens like Feline Herpesvirus or Swine Influenza, where shedding is typically shorter.

Clinical Manifestations and Symptomatology

The signs of EAV are highly variable. In many cases, the horse may appear healthy. However, when disease occurs, the following symptoms may be observed:

  • High fever

  • Conjunctivitis and ocular discharge

  • Nasal discharge

  • Limb edema (especially the hind limbs)

  • Abortion in pregnant mares

  • Skin rashes or papular eruptions

  • Depression and lethargy

Warning Signs of Severe Systemic Involvement

While most cases resolve, severe manifestations can occur, particularly in young foals or immunocompromised animals. Respiratory distress, severe weakness, and cardiovascular collapse are emergency indicators. Owners should monitor for rapid breathing and profound lethargy.

Diagnostic Protocols and Laboratory Testing

Veterinarians utilize several methods to confirm an EAV diagnosis. Because the clinical signs resemble other conditions like Feline Calicivirus in terms of ocular issues, definitive testing is required.

Virus Isolation and Serum Neutralization

The gold standard for diagnosis involves detecting the virus or antibodies. A blood sample is taken for serum neutralization, which quantifies the horse's antibody levels. Additionally, virus isolation from nasopharyngeal swabs or semen in stallions is essential for identifying carriers.

Management Strategies and Supportive Care

Treatment for EVA is largely supportive. Because it is a viral condition, antibiotics do not kill the virus; however, they may be prescribed to prevent secondary bacterial infections. Supportive care includes anti-inflammatory medication (like NSAIDs) to manage fever and pain, along with rest and isolation to prevent the spread to other horses. If the condition were compared to skin diseases like Ovine Foot Rot, it would be clear that environmental management is secondary to internal systemic support.

Long-Term Biosecurity and Prevention

Prevention is the most effective approach to managing EVA. An approved modified-live virus vaccine is available and highly effective. Maintaining strict biosecurity protocols for breeding programs is non-negotiable. Stallions should be tested for carrier status before being introduced to a farm, and any positive animals must be managed under strict quarantine protocols.